Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease
about
Asthma in sickle cell disease: implications for treatment.Placenta growth factor-induced early growth response 1 (Egr-1) regulates hypoxia-inducible factor-1alpha (HIF-1alpha) in endothelial cells.Acute chest syndrome: sickle cell disease.Asthma morbidity and treatment in children with sickle cell disease.Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.Inflammatory targets of therapy in sickle cell disease.Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell diseaseRole of biomarkers in understanding and treating children with asthma: towards personalized care.Asthma management in sickle cell diseaseLeukotriene pathway in sickle cell disease: a potential target for directed therapy.Leukotrienes and sex: strange bedfellows?Placental growth factor: What hematologists need to know.Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment.Placenta growth factor mediated gene regulation in sickle cell disease.Airway inflammation in sickle cell disease-A translational perspective.Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease.The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
P2860
Q33872120-9D4E3F19-8971-4D0C-9460-DCC1F8442933Q33966992-87CE3BE6-139D-4FB8-8717-2EDE01A8B94DQ34187526-5E085BA6-A977-4F22-A1F6-C3E201FF508FQ35599687-D1866927-E916-40CF-AEC1-B2A0ECADE300Q35672817-C1A9F818-0119-479D-826B-5F7799100607Q36385224-4B3BAF11-88BB-4590-9109-7F77B15914F6Q36515104-1ACF0B54-F0E1-4FD9-86E5-11AE60B72738Q37082000-CF9A061A-DCD8-41F9-B932-28C9C9817AE7Q37140629-AAC5F034-CDA7-4DA5-ACED-7DFB9357C9B3Q37346672-63FA65AC-C152-4259-930E-605B771B9F77Q37810108-5C4E8980-5D73-4140-A86F-4649D8A18EBCQ38652803-266D5BE5-6489-4828-BD15-AE62D77C0F87Q38823169-67BFDFB5-F338-4E29-8D41-79DF5A0B38ABQ40758763-3DA28B8B-0715-4B24-8BE2-2ABB22FF6F7DQ46063095-771E5898-BCEB-4A42-8897-07DE3AFF8E60Q47647345-C040EDB4-121A-4C85-9F1B-A2C1DFECB2A4Q48892688-6C79D469-B5FB-4FE5-A16C-6B6C4E9FD6A7Q50133441-DC3F11FB-BAB6-426C-B348-91EB0D1EDEDD
P2860
Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated urinary leukotriene E ...... ldren with sickle cell disease
@en
Elevated urinary leukotriene E ...... dren with sickle cell disease.
@nl
type
label
Elevated urinary leukotriene E ...... ldren with sickle cell disease
@en
Elevated urinary leukotriene E ...... dren with sickle cell disease.
@nl
prefLabel
Elevated urinary leukotriene E ...... ldren with sickle cell disease
@en
Elevated urinary leukotriene E ...... dren with sickle cell disease.
@nl
P2093
P2860
P356
P1476
Elevated urinary leukotriene E ...... ldren with sickle cell disease
@en
P2093
Jeanine E Jennings
Jessica Boyd
Jingnan Mao
Joshua J Field
Mario Castro
Michael R DeBaun
Robert C Strunk
Thiruvamoor Ramkumar
P2860
P304
P356
10.1002/AJH.21199
P577
2008-08-01T00:00:00Z